Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tianma Toufengling is a traditional Chinese patent medicine (TCM) developed and manufactured by Guizhou Yibai Pharmaceutical and its subsidiary Guizhou Yibai Women's Pharmacy. Formulated as an oral capsule, it is composed of ten traditional Chinese medicinal herbs: Gastrodia elata (Tianma), Achyranthes bidentata (Niuxi), Scrophularia ningpoensis (Xuanshen), Rehmannia glutinosa (Dihuang), Angelica sinensis (Danggui), Eucommia ulmoides (Duzhong), Ligusticum chuanxiong (Chuanxiong), Viscum coloratum (Hujisheng), Chrysanthemum indicum (Yejuhua), and Uncaria rhynchophylla (Gouteng). It is approved in China for the treatment of headaches (such as stubborn headaches), hand and foot numbness, and chronic waist and leg pain. The formulation acts by nourishing yin, suppressing hyperactive liver yang, dispelling wind, and strengthening muscles and bones.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tianma Toufengling.